Nexalife by Trivia Pharmaceuticals, LLC Nexalife

Nexalife by

Drug Labeling and Warnings

Nexalife by is a Other medication manufactured, distributed, or labeled by Trivia Pharmaceuticals, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

NEXALIFE- b-complex vitamin capsule 
Trivia Pharmaceuticals, LLC

----------

Nexalife

Health Claim Section:

Nexalife B-Complex Vitamin Capsules

Description:

Nexalife B-Complex Capsules are supplied as clear capsules dispensed in plastic bottles of 30 ct.

84781-0016-30

Reserved for Professional Recommendation

This listed product is not a National Drug Code, but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.

Manufactured for:
Trivia Pharmaceuticals

Gilbert, AZ

Warnings and Precautions:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

As with any supplement, if you are pregnant, nursing, taking medication, or have a medical condition, ask a health professional before taking this product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Dosage and Administration:

Usual adult dose is 1 capsule by mouth daily once daily, or as prescribed by a licensed medical practitioner.

Nexalife capsules is an orally administered prescription vitamin to provide significant amounts of B Vitamins and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamines will not develop.

How Supplied:

CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

PRECAUTIONS
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

ADVERSE REACTIONS
Allergic sensitizations have been reported following oral administration of folic acid. Consult your physician immediately if adverse side effects occur.

KEEP OUT OF THE REACH OF CHILDREN.

Storage:

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] Protect from light and moisture.

Label:

NEXALIFE 
b-complex vitamin capsule

Product Information
Product Type	DIETARY SUPPLEMENT	Item Code (Source)	NHRIC:84781-016
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
THIAMINE HCL (UNII: M572600E5P) (THIAMINE ION - UNII:4ABT0J945J)	THIAMINE HCL	1.5 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR)	RIBOFLAVIN	1.7 mg
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)	NIACINAMIDE	20 mg
PANTOTHENIC ACID (UNII: 19F5HK2737) (PANTOTHENIC ACID - UNII:19F5HK2737)	PANTOTHENIC ACID	10 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z)	PYRIDOXINE	2 mg
METHYLCOBALAMIN (UNII: BR1SN1JS2W) (METHYLCOBALAMIN - UNII:BR1SN1JS2W)	METHYLCOBALAMIN	6 ug
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)	FOLIC ACID	680 ug

Inactive Ingredients
Ingredient Name	Strength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:84781-016-30	30 in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
dietary supplement		08/13/2025	04/15/2026

Supplement Facts
Serving Size :		Serving per Container :
	Amount Per Serving	% Daily Value
color
shape
size (solid drugs)	25 mm
scoring	1

Labeler - Trivia Pharmaceuticals, LLC (119353862)

Revised: 4/2026

Document Id: 3cc299d1-2ee9-4f26-9b7f-4f777dcbd9c7

58476-3

Set id: 5ceffaa7-3f02-4833-bb55-f3cf437fe296

Version: 2

Effective Time: 20260415